rethinkPeptides Search
Menu
RethinkPeptides

GnRH and Endometriosis

Explore peptide research and guides on gnrh and endometriosis.

GnRH and Endometriosis

Elagolix and Relugolix: Oral GnRH Antagonists

Elagolix and relugolix are oral GnRH antagonists for endometriosis pain. We compare their Phase 3 trial data, bone density effects, and dosing tradeoffs.

GnRH and Endometriosis

GnRH Agonists for Endometriosis: How Suppression Treats Pain

GnRH agonists treat endometriosis by suppressing estrogen via pituitary downregulation. Pain relief in 50-90% of patients but bone loss limits monotherapy.

GnRH and Endometriosis

Peptide Approaches to Endometriosis Treatment

GnRH peptide agonists and oral antagonists for endometriosis pain, what clinical trials show for elagolix and relugolix, and emerging peptide targets.